🚀Phase 1 & 2 of WASHOUT is underway!

🙅Pre-registration is not OFFICIAL registration.

👉Register your site today to begin data collection ASAP. We want you!

🌍Official Registration: redcap.link/washoutregistr…

Fantastic #RESECT results (200 centres, n=16000). Cluster RCT in NMIBC - performance feedback & education ⬆️ documentation of tumour pattern & resection completeness but not MMC admin or detrusor muscle. 🚨Taking part in audit DID ⬇️ recurrence rates by 25%🚨 #EAU24 @uroweb

Fantastic work by Kevin Gallagher and BURST Urology Surely further evidence that the quality and outcome for every surgery should be recorded routinely, not just during a study. #ScottishQPI #Nationalbladdercanceraudit Prof Param Mariappan Lydia Makaroff

🗣️ Happening TODAY! The BURST-ESRU-YAU Global Collaborators Meeting at #EAU24 ‼️

⏰ 13:00 - 14:30 | 📍 Meeting Room 16

🎉 Reflecting on #RESECT 's milestones, honouring top collaborators, & unveiling our new study #WASHOUT 🥳

👀👀👀

Join us!!🔜

#UroSoMe

Delighted that the #RESECT study informed the #EAU24 plenary discussions to improve bladder cancer management. 19,000 patients cluster RCT, 200 sites. Join us on Sunday at 17.15 Purple area S03 for full trial results BURST Urology European Association of Urology (EAU) European Society of Residents in Urology Prof Param Mariappan Matt Nielsen, MD

No need for TURBT, VI-RADS makes the diagnosis. Presentation by Valeria Panebianco Sapienza University. #EAU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3U78VCe European Association of Urology (EAU)

⁦Veeru Kasi⁩ presents #PRIME trial results beautifully. Clear messages. If we can get the quality control & target group right, biparametric MRI offers a much-needed pressure release for our hard-pressed services. ⁦European Association of Urology (EAU)⁩ ⁦BAUS⁩ ⁦BURST Urology⁩

Want to free up operating theatre space and reduce BPH surgery waiting list by delivering Rezum in an outpatient setting under local anaesthetic? Here’s how to do it:
Feras Al Jaafari Stephanie Guillaumier Boston Scientific Urology #rezum

doi.org/10.1186/s12894…

🤔 Do you think #TURBTs are seen and respected as a cancer surgery?

📽️ Prof Jeremy Teoh emphasises the need for standardisation and better quality in TURBTs, looking forward to #RESECT results 👀

See you at #EAU24 !

📅 Sun 7 April | 🕔 17:15 | 📍 Purple Area, SO3

#UroSoMe

🚀 As we celebrate the strides made in #TURBT research with #RESECT …

🎉 Co-Investigator Nikita Bhatt shares her pride in RESECT's innovative approach.

🥇 With its design & live data dashboard, it’s not just the largest study but a series of remarkable firsts! 📈

#UroSoMe

📢 Kicking off our #RESECT countdown to #EAU24 with insights from BAUS President Jo Cresswell!

🎥 She discusses the importance of the world's largest #TURBT study & shares her anticipation for the upcoming results reveal 👀

🗓️ Sun 7 April | 17:15 | Purple Area, S03
#UroSoMe

A massive thank you to all our collaborators as RESECT approaches last 3 weeks of data collection with over 18,000 pts 🙌🏼 a truly global effort 🌍🏆We invite you to attend European Association of Urology (EAU) webinar on TURBT with experts on Thurs 6th July 18:00 BST. webinars.uroweb.org/EAU/webinars. Sign up today!

Celebrating collaborative research across Scottish Urology Centres with the award of best poster in session today at #BAUS23 with our project on malignant ureteric obstruction demonstrating variable outcomes in renal function recovery following decompression. BAUS

RESECT @ #BAUS23 ⬇️, a massive achievement as we now have ‼️17,000 ‼️ patients in our database 💪🏼. An unprecedented study thanks to the efforts of all collaborators, please use our novel data quality app to check the data you have entered. bursturo.shinyapps.io/Data_Quality/

RESECT: Tumor factors and variation in NMIBC recurrence after TURBT between sites Fortis UroToday.com #ASCO23

🔹 186 sites, contributing 4,597 cases (mean 25 cases)
🔹 Detrusor muscle resection: 75%
🔹 Single instillation of intravesical chemo: 42%
🔹 Med recur rate/site:

Congratulations to all our RESECT collaborators, we now have over 16,500 cases entered. The prospective phase deadline is fast approaching: you have until end of June 2023 to enter data. Don’t miss out and let your hard work go to waste! BSoT BAUS

Brilliant presentation of the RESECT study at Amer. Urol. Assn. #AUA2023 by Betty Wang Betty Wang. More to come from the RESECT study as we are close to completing our prospective phase. Currently we have >16000 cases, check where your centre ➡️bursturology.com/Studies/Resect….

Join us in S403 Amer. Urol. Assn. for the Bladder Cancer: Non Invasive session where our lead North American collaborator Betty Wang @hjwAng26 is presenting the RESECT study. BAUS EAU Young Urologists European Association of Urology (EAU) EAU Young Academics European Society of Residents in Urology USANZ

Beautiful buildings don't just appear.

Like McEwan Hall, where the University of Edinburgh holds graduation ceremonies. It was paid for by a local businessman...

⛑👀 endoscopic assessment of a suspected
#bladdercancer is essential to achieving a precise diagnosis & correct management.

👍to see more work spotlighting this disease

👏 Let's get it right all of the time!
#BURSTSoMe #UroSoMe #RESECT Kevin Gallagher Bladder Cancer Advocacy Network